The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma-Reference-Cited by-同舟云学术

The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma

Published:2015-11 Issue:4 Volume:93 Page:862-869
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Liu Li-Ting,Tang Lin-Quan,Chen Qiu-Yan,Zhang Lu,Guo Shan-Shan,Guo Ling,Mo Hao-Yuan,Zhao Chong,Guo Xiang,Cao Ka-Jia,Qian Chao-Nan,Zeng Mu-Sheng,Bei Jin-Xin,Hong Ming-Huang,Shao Jian-Yong,Sun Ying,Ma Jun,Mai Hai-Qiang

Funder

National Science Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference35 articles.

1. Nasopharyngeal carcinoma. Some observations on the clinical features and technique of examination;Choa;Pac Med Surg,1967

2. The prevalence and prevention of nasopharyngeal carcinoma in China;Cao;Chin J Cancer,2011

3. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099;Al-Sarraf;J Clin Oncol,1998

4. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival;Lin;J Clin Oncol,2003

5. Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma;Hong;J Clin Oncol,2001

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect analysis of 847 nasopharyngeal carcinoma cases treated with intensity modulated radiation: Experience and suggestions;Oral Oncology;2024-11

2. An individualized immune prognostic signature in nasopharyngeal carcinoma;Oral Oncology;2024-10

3. Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study;Cancer Cell;2024-08

4. Nomograms based on multiparametric MRI radiomics integrated with clinical-radiological features for predicting the response to induction chemotherapy in nasopharyngeal carcinoma;European Journal of Radiology;2024-06

5. Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma;Cell Reports Medicine;2024-06